Antiaggregant constitute a group of drugs that prevent the formation of blood clots. Therapy with antiplatelet drugs is prescribed only by a doctor in certain cardiovascular pathologies. When using such drugs, it is important to remember about possible side reactions.
Antiaggregant or antiplatelet drugs prevent the formation of blood clots in the arteries. Thienopyridine and its derivatives show antiplatelet properties when suppressing platelet aggregation, which is induced by adenosine diphosphate. Of platelets, ADP is released, and when they show activity, adenosine diphosphate interacts with two receptors.
The action of the drugs is based on the blockade of receptors on the platelet membrane. The active substance inhibits the aggregation of platelets. As a result, the binding of adenosine triphosphate to their receptors is blocked.
The effect of antiplatelet agents is aimed at preventing the formation of blood clots and are prescribed to patients with a high risk of formation of blood clots.
The action of anticoagulants is aimed at preventing the formation and increase of blood clots, which can clog the vessel. This reduces the risk of stroke and heart attack. Unlike anticoagulants, antiplatelet agents have a mild effect.
The main value in the use of these drugs is to reduce blood viscosity, improve fluidity and normalize blood supply. It is important to know that the combined use of anticoagulants and antiaggregants is undesirable. If you are using any of the drugs in this category, tell your doctor.